Further multivariate analysis showed that tumor diameter, lymph node metastasis and skin viscosity were the risk factors affecting the expression level of BRCA2, and tumor differentiation was the protective factor. Here, BRCA2 is linked to metastatic malignant neoplasm in the lymph nodes.